Pandemic influenza A vaccination and incidence of Guillain-Barre syndrome in Korea

被引:15
|
作者
Kim, Changsoo [1 ]
Rhie, Seonkyeong [2 ]
Suh, Mina [3 ]
Kang, Dae Ryong [4 ]
Choi, Yoon Jung [5 ]
Bae, Geun-Ryang [6 ]
Choi, Young-Chul [7 ]
Jun, Byung Yool [8 ]
Lee, Joon Soo [9 ]
机构
[1] Yonsei Univ, Coll Med, Dept Prevent Med, Seoul 120752, South Korea
[2] CHA Univ, CHA Bundang Med Ctr, Dept Pediat, Songnam, South Korea
[3] Natl Canc Ctr, Goyang, South Korea
[4] Yonsei Univ, Coll Med, Biostat Collaborat Unit, Seoul 120752, South Korea
[5] Hlth Insurance Review & Assessment Serv, Seoul, South Korea
[6] Korea Ctr Dis Control & Prevent, Osong, South Korea
[7] Yonsei Univ, Gangnam Severance Hosp, Coll Med, Dept Neurol, Seoul 120752, South Korea
[8] Yonsei Univ, Grad Sch Publ Hlth, Dept Int Hlth Sci, Seoul 120752, South Korea
[9] Yonsei Univ, Severance Childrens Hosp, Epilepsy Res Ctr, Coll Med,Dept Pediat, Seoul 120752, South Korea
关键词
Guillain-Barre syndrome; Influenza; Incidence rate; Vaccination; EVENTS FOLLOWING RECEIPT; 2009; H1N1; VACCINE; UNITED-STATES; IMMUNIZATION; SAFETY; RISK; SURVEILLANCE; CAMPYLOBACTER; ASSOCIATION; MORTALITY;
D O I
10.1016/j.vaccine.2015.02.035
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Many studies have investigated the association between Guillain-Barre syndrome (GBS) and vaccinations during the influenza A H1N1 pandemic of 2009 (pH1N1). Based on a nationally representative sample, we estimated the incidence of GBS during the pandemic period in Korea. Materials and methods: All medical records of CBS cases were reviewed in 28 randomly selected hospitals during 2008-2010, and the number of CBS cases at the national level was extrapolated using emergency care utilization data. The CBS rate per 100,000 person-years was estimated in the reference and pandemic periods. Results: The incidence of CBS was 0.63 (95% CI: 0.37-0.89) per 100,000 person-years in the reference period and 0.87(0.49-1.26) in the pandemic period. During the vaccination season, the pandemic period CBS incidence rate was not significantly higher than the reference period incidence rate (rate ratio: 1.52; 0.99-2.32), but difference was observed among persons aged 20-34 years. Rate of CBS increased after pH1N1 vaccination compared to the reference period (1.46,1.26-1.68). Discussion: The incidence of CBS increased slightly but not significantly during the pandemic period, although pH1N1 vaccination increased the CBS rate. Therefore,, mass influenza vaccination programs should not be precluded on the basis of CBS. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1815 / 1823
页数:9
相关论文
共 50 条
  • [41] Post-COVID vaccination Guillain-Barre syndrome
    Finsterer, Josef
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (03) : 1224 - 1225
  • [42] CASE OF GUILLAIN-BARRE SYNDROME FOLLOWING CHOLERA VACCINATION
    SCHRADER, H
    JOURNAL OF NEUROLOGY, 1975, 209 (01) : 69 - 74
  • [44] Guillain-Barre syndrome after exposure to influenza virus
    Lehmann, Helmar C.
    Hartung, Hans-Peter
    Kieseier, Bernd C.
    Hughes, Richard A. C.
    LANCET INFECTIOUS DISEASES, 2010, 10 (09): : 643 - 651
  • [45] Guillain-Barre syndrome and influenza vaccines: current evidence
    Sanz Fadrique, Rosario
    Arias, Luis Martin
    Arcadio Molina-Guarneros, Juan
    Jimeno Bulnes, Natalia
    Garcia Ortega, Pilar
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2019, 32 (04) : 288 - 295
  • [46] Guillain-Barre syndrome and anti-hepatitis A vaccination
    Roux, X.
    Gramond, C.
    De Greslan, T.
    Sallansonnet-Froment, M.
    Aoun, O.
    Ouologuem, M.
    Taillia, H.
    Renard, J. -L.
    MEDECINE ET MALADIES INFECTIEUSES, 2010, 40 (08): : 490 - 492
  • [47] Guillain-Barre syndrome following oral polio vaccination
    Naeem, Salman
    Shabbir, Asma
    Khan, Abdus Salam
    Ahmad, Samia
    Mustafa, Khawaja Junaid
    Fahim, Ammad
    JOURNAL OF NEUROVIROLOGY, 2016, 22 (04) : 546 - 549
  • [48] Guillain-Barre Syndrome: The role of influenza vaccines and infection
    Kurland, LT
    Wiederholt, WC
    Beghi, E
    Kirkpatrick, JW
    BRAIN PATHOLOGY, 1997, 7 (04) : 1195 - 1195
  • [49] Risk of Guillain-Barre syndrome following pandemic influenza A (H1N1) 2009 vaccination in Germany
    Prestel, Juergen
    Volkers, Peter
    Mentzer, Dirk
    Lehmann, Helmar C.
    Hartung, Hans-Peter
    Keller-Stanislawski, Brigitte
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 (11) : 1192 - 1204
  • [50] RECURRENT GUILLAIN-BARRE SYNDROME FOLLOWING INFLUENZA VACCINE
    SEYAL, M
    ZIEGLER, DK
    COUCH, JR
    NEUROLOGY, 1978, 28 (07) : 725 - 726